Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lispro Mixtures vs Glargine Basal-Bolus in Type 2 Diabetes
NCT00110370Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2004; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00110370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110370.